Advances in Treating Tardive Dyskinesia

Strategies for treating tardive dyskinesia (TD).
John M. Kane, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.79 MB
Released: October 1, 2021


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Neurocrine Biosciences

Related Content

Dr Greg Mattingly reviews the latest available clinical data for emerging diagnostic and therapy options for managing the mood disorders and TD, from Clinical Care Options (CCO)

Greg Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: November 22, 2021 Expired: November 21, 2022

Clinical Care Options (CCO) commentary by Sanjay Gupta, MD, on choosing the right VMAT2 inhibitor for TD

Sanjay Gupta, MD Released: November 19, 2021

In this activity, a panel of Sanjay Gupta, MD reviews salient research studies of interest relevant to depression, schizophrenia, ADHD and substance abuse and provides clinical commentary

Sanjay Gupta, MD Released: November 18, 2021

Commentary by Manish Jha, MD, on weight gain and metabolic differences in agents used for bipolar depression, from Clinical Care Options (CCO)

Manish Jha, MD Released: November 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.